AFMD Affimed NV

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

For the month of June, 2022

Commission File Number: 001-36619

Affimed N.V.

Im Neuenheimer

Feld 582, 69120 Heidelberg, Germany

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒                 Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Annual General Meeting Results

On June 22, 2022, Affimed N.V. (“Affimed” or the “Company”) held its Annual General Meeting of Shareholders. The final results of each of the agenda items submitted to a vote of the shareholders are as follows:

Agenda item 3: Adoption of the Statutory Annual Accounts for the financial year 2021

Affimed shareholders approved the adoption of the statutory annual accounts for the financial year 2021.

Agenda item 4: Discharge of the managing directors for their management during the financial year 2021

Affimed shareholders approved the discharge of the managing directors for their management during the financial year 2021.

Agenda item 5: Discharge of the supervisory directors for their supervision during the financial year 2021

Affimed shareholders approved the discharge of the supervisory directors for their supervision during the financial year 2021.

Agenda item 6(b): Amendment of the Remuneration Policy for the Management Board

Affimed shareholders approved the amendment of its Remuneration Policy for the Management Board.

Agenda item 6(c): Amendment of the Remuneration Policy for the Supervisory Board

Affimed shareholders approved the amendment of its Remuneration Policy for the Supervisory Board.

Agenda item 7: Reappointment of Dr. Bernhard Ehmer as a supervisory director

Affimed shareholders approved the reappointment of Dr. Bernhard Ehmer as a supervisory director.

Agenda item 8: Appointment of the auditor for the financial year 2022

Affimed shareholders approved the appointment of the auditor for the financial year 2022.

Agenda item 9: Authorization to acquire shares

Affimed shareholders approved the authorization to acquire shares.

3